10:10 am Ariad Pharm announces U.S. resumption of marketing and commercial distribution of Iclusig (ponatinib) in refractory Philadelphia-positive leukemiasBriefing.com(Fri 10:10AM EST)
ARIA!
ARIAD Announces U.S. Resumption of Marketing and Commercial Distribution of Iclusig (ponatinib) in Refractory Philadelphia-Positive Leukemias
10:10 am Ariad Pharm announces U.S. resumption of marketing and commercial distribution of Iclusig (ponatinib) in refractory Philadelphia-positive leukemiasBriefing.com(Fri 10:10AM EST)
10:10 am Ariad Pharm announces U.S. resumption of marketing and commercial distribution of Iclusig (ponatinib) in refractory Philadelphia-positive leukemiasBriefing.com(Fri 10:10AM EST)